Share your research articles, interpretations and experiences here. Let us know how these studies affect you and your decisions.
Posted on: Sep 19, 2020 12:41PM
I have been waiting for significant data on this subject ("liquid biopsy") for 2 decades now. Even with many tumor sites, it's always risky to get my wife biopsy. Due to tumor heterogeneity one can only hope the biopsy sample represents the biology of the majority of tumor. With CTC, my lay person thinking is that CTCs represent the majority and particularly the more dangerous type that likely settle to other parts of the body. So here we are, fresh off the ongoing 2020 ESSO conference.